Cartesian Therapeutics Inc (NAS:RNAC)
$ 28 3.69 (15.02%) Market Cap: 498.29 Mil Enterprise Value: 344.29 Mil PE Ratio: 0 PB Ratio: 0 GF Score: 48/100

Q2 2019 Selecta Biosciences Inc Earnings Call Transcript

Aug 08, 2019 / 12:30PM GMT
Release Date Price: $53.4 (-7.29%)
Operator

Good morning. Thank you for holding. Welcome to the Selecta Biosciences Second Quarter Financial Results Conference Call. (Operator Instructions) This call is being webcast live on the Investors and Media section of Selecta's website at www.selectabio.com and it is being recorded.

For opening remarks, I would now like to turn the call over to Elona Kogan. Please go ahead.

Elona Kogan
Selecta Biosciences, Inc. - General Counsel & Corporate Secretary

Thank you, and good morning, everyone. Earlier today, we issued a press release containing our second quarter 2019 financial results and other corporate updates, and we filed our 10-Q. This release and the 10-Q can be accessed by visiting our website at www.selectabio.com. I'm joined today by Carsten Brunn, our CEO; and Stephen Smolinski, our CCO, and Dr. Kei Kishimoto, our scientific -- Chief Scientific Officer, who will be available for the Q&A portion of the call.

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot